LakeShore Historical Income Statement
| LSBPW Stock | 0.05 0 4.19% |
Historical analysis of LakeShore Biopharma income statement accounts such as Selling And Marketing Expenses of 211 M can show how well LakeShore Biopharma Co, performed in making a profits. Evaluating LakeShore Biopharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of LakeShore Biopharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining LakeShore Biopharma Co, latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LakeShore Biopharma Co, is a good buy for the upcoming year.
LakeShore |
About LakeShore Income Statement Analysis
LakeShore Biopharma Co, Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to LakeShore Biopharma shareholders. The income statement also shows LakeShore investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
LakeShore Biopharma Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts LakeShore Biopharma Co, generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of LakeShore Biopharma Co, minus its cost of goods sold. It is profit before LakeShore Biopharma operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Operating Income
Operating Income is the amount of profit realized from LakeShore Biopharma Co, operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of LakeShore Biopharma Co, is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on LakeShore Biopharma income statement and is an important metric when analyzing LakeShore Biopharma Co, profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from LakeShore Biopharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into LakeShore Biopharma Co, current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. Total Operating Expenses is likely to climb to about 1.1 B in 2025, despite the fact that Tax Provision is likely to grow to (18.6 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 30.9M | 44.3M | 51.0M | 29.6M | Depreciation And Amortization | 36.7M | 42.2M | 48.5M | 37.9M |
LakeShore Biopharma income statement Correlations
Click cells to compare fundamentals
LakeShore Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.